Diagnosis and Outcomes of 341 Patients with Cushing's Disease Following Transsphenoid Surgery: A Single-Center Experience.

Abstract

Transsphenoid surgery (TSS) is a standard treatment modality for Cushing's disease (CD). However, postoperative remission and recurrence rates vary among studies. Here we analyze the diagnosis and outcomes of 341 patients with a preoperative diagnosis of CD undergoing TSS in a single center over a 3-year period. A total of 341 patients were enrolled. Clinical manifestations, imaging results, laboratory workups, and results of inferior petrosal sinus sampling (IPSS) were obtained. Outcomes were obtained with a follow-up length from 12 to 36 months. The tumors were mainly of Knosp level 0 (68.57%). The sensitivity of MRI, combined low-dose and high-dose dexamethasone suppression test and IPSS in the diagnosis were 90.83%, 88.53% and 95.57%. The concordance of lateralization by MRI and by IPSS were 78.96% and 61.34% compared with surgery. 2. The overall remission rate was 78.89% (N= 289). Patients undergoing the first TSS (N= 234) had a remission rate of 86.36% for macroadenomas (N= 22) and 83.2% for microadenomas (N= 212). Patients undergoing a second TSS (N= 55) had lower rate of remission of 50.00% for macroadenomas (N= 6) and 61.22% for microadenomas (N= 49). For patients with invasive tumors, the overall remission rate was 26.92% (N= 26), 20.0% for macroadenomas (n= 20) and 50.0% for microadenomas (N= 6). The recurrence rate was 2.42%. Pituitary imaging, endocrinological workups and IPSS are sensitive and specific diagnostic modalities for CD, but the lateralization efficacy of MRI and IPSS are unsatisfactory. A higher rate of remission relies on gross resections of tumors.